CB1R Antagonist 1(Cat No.:I043345)is a selective compound that blocks the CB1 receptor, a key component of the endocannabinoid system involved in regulating various physiological processes, including appetite, mood, and pain. By inhibiting CB1 receptor activity, this antagonist can modulate pathways related to obesity, addiction, and metabolic disorders. It has potential therapeutic applications in weight management and addiction treatments by reducing appetite and curbing the rewarding effects of certain substances. CB1R Antagonist 1 is being explored in preclinical studies as a tool for developing targeted therapies with fewer side effects compared to traditional treatments.